Top Healthcare Compliance Officer Joins Board of Directors at Leading Genetics Company
Irvine, CA (PRWEB) May 10, 2016
Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the appointment of John Steiner, Esq., to the Board of Directors. Steiner is the Senior Vice President, Privacy Officer and Associate General Counsel for Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Florida. Steiner, a nationally recognized expert in compliance and federal healthcare law, is responsible for the design, implementation and administration of the enterprise compliance program. “We’re honored to bring a leading authority in healthcare compliance to the team,” said Brian Meshkin, CEO at Proove Biosciences. “Cancer Treatment Centers of America is at the forefront of cancer care with its focused on precision care, advanced technology, and genomic testing—and we’re excited to leverage Mr. Steiner’s expertise.”
Throughout his distinguished career, Steiner maintained affiliations and leadership positions with the HealthCare Compliance Association, the American Bar Association, and the Personalized Medicine Coalition. He is a nationally recognized author and speaker on health law and compliance.
Previously, Steiner led compliance efforts for the Cleveland Clinic Health System, served as Senior Counsel for the American Hospital Association, and led the compliance program for UK HealthCare at the University of Kentucky. “We’re excited to bring Steiner’s experience and expertise to Proove as we continue to build a world-class operation that delivers precision medicine to people throughout the United States and Canada,” continued Meshkin. Steiner earned his undergraduate degree from The John Hopkins University and his law degree, with honors, from Chicago-Kent College of Law, Chicago, Illinois.
About Proove Biosciences
Our mission is to change the future of medicine. Proove represents the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could have ever prescribed medications without knowing how a patient would respond. Physicians use Proove Biosciences testing to improve outcomes—both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).
For the original version on PRWeb visit: http://www.prweb.com/releases/2016/05/prweb13406016.htm